These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31629653)

  • 1. MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.
    Ryman SG; Poston KL
    Parkinsonism Relat Disord; 2020 Apr; 73():85-93. PubMed ID: 31629653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional MRI in Parkinson's Disease Cognitive Impairment.
    Baggio HC; Junqué C
    Int Rev Neurobiol; 2019; 144():29-58. PubMed ID: 30638456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease.
    Tambasco N; Paolini Paoletti F; Chiappiniello A; Lisetti V; Nigro P; Eusebi P; Chiarini P; Romoli M; Brahimi E; Simoni S; Filidei M; Floridi P; Tarducci R; Parnetti L; Calabresi P
    Neurobiol Aging; 2019 Aug; 80():91-98. PubMed ID: 31103636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
    Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N
    Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus.
    Li Y; Wang C; Wang J; Zhou Y; Ye F; Zhang Y; Cheng X; Huang Z; Liu K; Fei G; Zhong C; Zeng M; Jin L
    Mov Disord; 2019 Jun; 34(6):884-892. PubMed ID: 30938892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional MRI in Idiopathic Parkinson's Disease.
    Filippi M; Elisabetta S; Piramide N; Agosta F
    Int Rev Neurobiol; 2018; 141():439-467. PubMed ID: 30314606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease.
    Hirano S
    Mol Med; 2021 Apr; 27(1):40. PubMed ID: 33858320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Resting Magnetic Resonance Imaging in the Cognitive Judgment of Parkinson.
    Mu L; Zhou Q; Sun D; Wang M; Chai X; Wang M
    World Neurosurg; 2020 Jun; 138():672-679. PubMed ID: 32545020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.
    Ruppert MC; Greuel A; Tahmasian M; Schwartz F; Stürmer S; Maier F; Hammes J; Tittgemeyer M; Timmermann L; van Eimeren T; Drzezga A; Eggers C
    Brain; 2020 Mar; 143(3):944-959. PubMed ID: 32057084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Correlates of Cognitive Impairment in Parkinson's Disease: A Review of Structural MRI Findings.
    Hall JM; Lewis SJG
    Int Rev Neurobiol; 2019; 144():1-28. PubMed ID: 30638452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
    Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
    Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
    Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
    Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease.
    Zarkali A; McColgan P; Leyland LA; Lees AJ; Weil RS
    Mov Disord; 2021 May; 36(5):1191-1202. PubMed ID: 33421201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
    Bohnen NI; Müller ML; Zarzhevsky N; Koeppe RA; Bogan CW; Kilbourn MR; Frey KA; Albin RL
    Brain; 2011 Aug; 134(Pt 8):2358-65. PubMed ID: 21653540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
    Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
    BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
    Delgado-Alvarado M; Gago B; Navalpotro-Gomez I; Jiménez-Urbieta H; Rodriguez-Oroz MC
    Mov Disord; 2016 Jun; 31(6):861-81. PubMed ID: 27193487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture features of magnetic resonance images: A marker of slight cognitive deficits in Parkinson's disease.
    Betrouni N; Lopes R; Defebvre L; Leentjens AFG; Dujardin K
    Mov Disord; 2020 Mar; 35(3):486-494. PubMed ID: 31758820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.